Literature DB >> 25384505

Predictors of contralateral anterior cruciate ligament reconstruction: a cohort study of 9061 patients with 5-year follow-up.

Daniel Andernord1, Neel Desai2, Haukur Björnsson2, Sofia Gillén3, Jón Karlsson2, Kristian Samuelsson2.   

Abstract

BACKGROUND: Identifying predictors of contralateral anterior cruciate ligament (ACL) reconstruction is important to focus preventive strategies and related research on high-risk groups.
PURPOSE: To investigate predictors of contralateral ACL reconstruction in patients who have already undergone a primary ipsilateral reconstruction. STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: This study was based on data from the Swedish National Knee Ligament Register from January 1, 2005, to December 31, 2013. Patients aged 13 to 59 years who underwent primary ipsilateral (index) ACL reconstruction with hamstring tendon or bone-patellar tendon-bone autografts were included. Follow-up started on date of index ACL reconstruction and ended either with primary contralateral ACL reconstruction, after 5 years of follow-up, or on December 31, 2013, whichever occurred first. The investigated variables were patient sex, age at index reconstruction, activity at the time of index injury, timing of surgery, graft selection, graft harvest site, and meniscal and chondral injury. The study end point was primary contralateral ACL reconstruction. Relative risks (RRs) and 95% CIs were calculated and adjusted for confounding factors using multivariate statistics.
RESULTS: A total of 9061 participants were included (n = 5196 males [57.3%] and 3865 females [42.7%]), of which 270 participants (3.0%) underwent primary contralateral ACL reconstruction during the 5-year follow-up. There was no difference in contralateral reconstruction rates between males and females (3.0% vs 2.9%, P = .695). Age <20 years significantly increased the risk of contralateral reconstruction (males: RR = 2.4 [95% CI, 1.7-3.4] and females: RR = 2.9 [95% CI, 1.9-4.5]; P < .001). Among female patients undergoing reconstruction using autograft hamstring, harvest of a contralateral hamstring tendon significantly increased this risk (RR = 3.4 [95% CI, 1.4-7.9]; P = .006).
CONCLUSION: In both male and female participants, age <20 years predicted an almost 3 times higher 5-year risk of contralateral ACL reconstruction. Among female participants undergoing reconstruction with autograft hamstring, a contralateral harvest predicted a more than 3 times higher 5-year risk of contralateral ACL reconstruction. Patient sex, activity at the time of index injury, graft selection, meniscal injury, and chondral injury were not predictors of contralateral ACL reconstruction.
© 2014 The Author(s).

Entities:  

Keywords:  anterior cruciate ligament; autograft; contralateral; knee; reconstruction; registry

Mesh:

Year:  2014        PMID: 25384505     DOI: 10.1177/0363546514557245

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  24 in total

1.  Incidence and Predictors of Second Anterior Cruciate Ligament Injury After Primary Reconstruction and Return to Sport.

Authors:  Mark V Paterno
Journal:  J Athl Train       Date:  2015-10       Impact factor: 2.860

2.  Risk Factors and Predictors of Subsequent ACL Injury in Either Knee After ACL Reconstruction: Prospective Analysis of 2488 Primary ACL Reconstructions From the MOON Cohort.

Authors:  Christopher C Kaeding; Angela D Pedroza; Emily K Reinke; Laura J Huston; Kurt P Spindler
Journal:  Am J Sports Med       Date:  2015-04-21       Impact factor: 6.202

3.  Hospital for Special Surgery ACL Registry: 2-Year Outcomes Suggest Low Revision and Return to OR Rates.

Authors:  Moira McCarthy; Katherine Mallett; Matthew Abola; Sherrie Vassallo; Joseph Nguyen
Journal:  HSS J       Date:  2016-11-22

Review 4.  Paediatric Anterior Cruciate Ligament (ACL) Injuries: Current Concepts Review.

Authors:  Mandeep Singh Dhillon; Karthick Rangasamy; Rajesh Kumar Rajnish; Nirmal Raj Gopinathan
Journal:  Indian J Orthop       Date:  2022-04-09       Impact factor: 1.033

Review 5.  When Is It Safe to Return to Sport After ACL Reconstruction? Reviewing the Criteria.

Authors:  Yonatan Kaplan; Erik Witvrouw
Journal:  Sports Health       Date:  2019-05-28       Impact factor: 3.843

6.  Patient-Related Risk Factors for Contralateral Anterior Cruciate Ligament (ACL) Tear After ACL Reconstruction: An Analysis of 3707 Primary ACL Reconstructions.

Authors:  Jourdan M Cancienne; Robert Browning; Brian C Werner
Journal:  HSS J       Date:  2019-05-30

7.  One in 5 Athletes Sustain Reinjury Upon Return to High-Risk Sports After ACL Reconstruction: A Systematic Review in 1239 Athletes Younger Than 20 Years.

Authors:  Sue Barber-Westin; Frank R Noyes
Journal:  Sports Health       Date:  2020-05-06       Impact factor: 3.843

8.  Association of Prior Anterior Cruciate Ligament Tear With Decreased Career Longevity in Women's National Basketball Association.

Authors:  Joseph S Tramer; Lafi S Khalil; Toufic R Jildeh; Mohammad Sattar; Alexander Ziedas; Muhammad J Abbas; Patricia A Kolowich; Kelechi R Okoroha
Journal:  Orthop J Sports Med       Date:  2021-06-25

9.  Risk Factors for Contra-Lateral Secondary Anterior Cruciate Ligament Injury: A Systematic Review with Meta-Analysis.

Authors:  Anna Cronström; Eva Tengman; Charlotte K Häger
Journal:  Sports Med       Date:  2021-01-30       Impact factor: 11.136

10.  2018 International Olympic Committee consensus statement on prevention, diagnosis and management of paediatric anterior cruciate ligament (ACL) injuries.

Authors:  Clare L Ardern; Guri Ekås; Hege Grindem; Håvard Moksnes; Allen Anderson; Franck Chotel; Moises Cohen; Magnus Forssblad; Theodore J Ganley; Julian A Feller; Jón Karlsson; Mininder S Kocher; Robert F LaPrade; Mike McNamee; Bert Mandelbaum; Lyle Micheli; Nicholas Mohtadi; Bruce Reider; Justin Roe; Romain Seil; Rainer Siebold; Holly J Silvers-Granelli; Torbjørn Soligard; Erik Witvrouw; Lars Engebretsen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-02-17       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.